Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File No. 0-20292

 


 

AMPEX CORPORATION

(Exact name of Registrant as specified in its charter)

 


 

Delaware   13-3667696
(State of Incorporation)   (I.R.S. Employer Identification Number)

 

1228 Douglas Avenue

Redwood City, California 94063-3199

(Address of principal executive offices, including zip code)

 

(650) 367-2011

(Registrant’s telephone number, including area code)

 


 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

 

As of September 30, 2004, the aggregate number of outstanding shares of our Class A Common Stock, $.01 par value, was 3,642,517. There were no outstanding shares of our Class C Common Stock, $0.01 par value.

 



Table of Contents

AMPEX CORPORATION

FORM 10-Q

 

Quarter Ended September 30, 2004

 

INDEX

 

          Page

PART I — FINANCIAL INFORMATION

    

Item 1.

  

Financial Statements

    
    

Consolidated Balance Sheets (unaudited) at September 30, 2004 and December 31, 2003

   3
     Consolidated Statements of Operations and Comprehensive Income (Loss) (unaudited) for the three and nine months ended September 30, 2004 and 2003    4
    

Consolidated Statements of Cash Flows (unaudited) for the nine months ended September 30, 2004 and 2003

   5
    

Notes to Unaudited Consolidated Financial Statements

   6

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   20

Item 3.

  

Quantitative and Qualitative Disclosure about Market Risk

   38

Item 4.

  

Controls and Procedures

   38

PART II — OTHER INFORMATION

    

Item 1.

  

Legal Proceedings

   38

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

   39

Item 3.

  

Defaults Upon Senior Securities

   40

Item 4.

  

Submission of Matters to a Vote of Security Holders

   40

Item 5.

  

Other Information

   40

Item 6

  

Exhibits

   40

Signatures

   41

 

2


Table of Contents

AMPEX CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

 

     September 30,
2004


    December 31,
2003


 
     (unaudited)        

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 5,451     $ 14,023  

Short-term investments

     9,160       —    

Accounts receivable (net of allowances of $88 in 2004 and $137 in 2003)

     2,892       4,513  

Inventories

     6,184       6,343  

Other current assets

     4,052       4,366  
    


 


Total current assets

     27,739       29,245  

Property, plant and equipment

     4,333       4,825  

Other assets

     598       1,127  
    


 


Total assets

   $ 32,670     $ 35,197  
    


 


LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT

                

Current liabilities:

                

Notes payable

   $ 132     $ 146  

Accounts payable

     2,579       1,511  

Net liabilities of discontinued operations

     807       1,076  

Accrued restructuring costs

     631       1,300  

Other accrued liabilities

     11,890       23,956  
    


 


Total current liabilities

     16,039       27,989  

Long-term debt

     89,560       74,022  

Other liabilities

     63,618       63,802  

Accrued restructuring costs

     1,794       3,450  

Net liabilities of discontinued operations

     1,354       2,071  
    


 


Total liabilities

     172,365       171,334  
    


 


Commitments and contingencies (Note 10)

                

Mandatorily redeemable nonconvertible preferred stock, $1,000 liquidation value:

                

Authorized: 69,970 shares in 2004 and in 2003

                

Issued and outstanding - none in 2004 and in 2003

     —         —    

Mandatorily redeemable preferred stock, $2,000 liquidation value:

                

Authorized: 21,859 shares in 2004 and in 2003

                

Issued and outstanding - none in 2004 and in 2003

     —         —    

Convertible preferred stock, $2,000 liquidation value:

                

Authorized: 10,000 shares in 2004 and in 2003

                

Issued and outstanding - none in 2004 and in 2003

     —         —    

Stockholders’ deficit:

                

Preferred stock, $1.00 par value:

                

Authorized: 898,171 shares in 2004 and in 2003

                

Issued and outstanding - none in 2004 and in 2003

     —         —    

Common stock, $.01 par value:

                

Class A:

                

Authorized: 175,000,000 shares in 2004 and in 2003

                

Issued and outstanding - 3,642,517 shares in 2004; 3,728,017 in 2003

     36       37  

Class C:

                

Authorized: 50,000,000 shares in 2004 and in 2003

                

Issued and outstanding - none in 2004 and in 2003

     —         —    

Other additional capital

     454,468       454,394  

Accumulated deficit

     (523,581 )     (518,578 )

Accumulated other comprehensive loss

     (70,618 )     (71,990 )
    


 


Total stockholders’ deficit

     (139,695 )     (136,137 )
    


 


Total liabilities, redeemable preferred stock and stockholders’ deficit

   $ 32,670     $ 35,197  
    


 


 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

3


Table of Contents

AMPEX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(in thousands, except share and per share data)

 

     For the Three Months Ended
September 30,


    For the Nine Months Ended
September 30,


 
     2004

    2003

    2004

    2003

 
     (unaudited)  

Licensing revenue

   $ 1,759     $ 1,744     $ 4,861     $ 7,702  

Product revenue

     4,390       6,367       15,767       17,950  

Service revenue

     2,173       2,065       6,496       7,049  
    


 


 


 


Total revenue

     8,322       10,176       27,124       32,701  
    


 


 


 


Intellectual property costs

     1,653       205       4,595       796  

Cost of product sales

     3,069       3,848       9,955       10,712  

Cost of service

     688       747       2,342       2,375  

Research, development and engineering

     1,022       696       2,853       2,326  

Selling and administrative

     3,326       2,848       9,160       9,095  

Restructuring charges (credits)

     (1,410 )     —         (1,410 )     —    
    


 


 


 


Total costs and operating expenses

     8,348       8,344       27,495       25,304  
    


 


 


 


Operating income (loss)

     (26 )     1,832       (371 )     7,397  

Interest expense

     2,534       2,215       7,312       6,716  

Amortization of debt financing costs

     14       15       42       43  

Interest income

     (30 )     (57 )     (88 )     (86 )

Other (income) expense, net

     (385 )     2       (381 )     35  
    


 


 


 


Income (loss) from continuing operations before income taxes and equity in income of limited partnership, including sale of investment

     (2,159 )     (343 )     (7,256 )     689  

Provision for (benefit of) income taxes

     —         (3,981 )     248       (3,306 )

Equity in income of limited partnership, including sale of investment

     (591 )     —         (2,149 )     —    
    


 


 


 


Net income (loss) from continuing operations (Note 5)

     (1,568 )     3,638       (5,355 )     3,995  

Income from discontinued operations (net of taxes of nil in 2004)

     352       —         352       —    
    


 


 


 


Net income (loss)

     (1,216 )     3,638       (5,003 )     3,995  

Benefit from extinguishment of mandatorily redeemable preferred stock

             974               3,041  

Preferred dividends ascribed, but not declared

     —         (451 )     —         (1,416 )
    


 


 


 


Undistributed net income (loss) applicable to common stockholders

     (1,216 )     4,161       (5,003 )     5,620  

Other comprehensive income (loss), net of tax:

                                

Foreign currency translation adjustments

     2       (67 )     46       (54 )
    


 


 


 


Comprehensive income (loss)

   $ (1,214 )   $ 4,094     $ (4,957 )   $ 5,566  
    


 


 


 


Basic and diluted undistributed income (loss) per share (Note 5) :

                                

Undistributed income (loss) per share from continuing operations

   $ (0.43 )   $ 0.98     $ (1.46 )   $ 0.80  

Income per share from discontinued operations

   $ 0.10     $ —       $ 0.10     $ —    

Undistributed income (loss) per share applicable to common stockholders

   $ (0.33 )   $ 1.28     $ (1.36 )   $ 1.75  
    


 


 


 


Weighted average number of basic and diluted common shares outstanding

     3,642,517       3,260,733       3,667,572       3,207,382  
    


 


 


 


 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4